Corrigendum: Case Report: A False Negative Case of Anti-Yo Paraneoplastic Myelopathy

Front Neurol. 2022 Mar 23:13:888513. doi: 10.3389/fneur.2022.888513. eCollection 2022.

Christopher M Bartley^{1

2}, Neelroop N Parikshak^{1

3}, Thomas T Ngo^{1

2}, Jessa A Alexander^{1

3}, Kelsey C Zorn⁴, Bonny D Alvarenga^{1

3}, Min K Kang^{1

3}, Massimo Pedriali⁵, Samuel J Pleasure^{1

3}, Michael R Wilson^{1

3}

¹ Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, United States.
² Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco, CA, United States.
³ Department of Neurology, University of California, San Francisco, San Francisco, CA, United States.
⁴ Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA, United States.
⁵ Operative Unit of Surgical Pathology, Azienda Ospedaliera-Universitaria, Ferrara, Italy.

Abstract

[This corrects the article DOI: 10.3389/fneur.2021.728700.].

Keywords: CDR2L; anti-Yo antibodies; breast cancer; myelopathy; paraneoplastic neurologic disease; phage display.